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Dear Editor,
I would like to thank Dr Sendi and Mohseni for their in-
terest in our study.In this letter the authors have summa-
rized the contributory effects of hereditary hemochro-
matosis (HH) in liver diseases in different populations (1). 
I completely agree with them concerning the underlying 
causes of cryptogenic cirrhosis which in countries such 
as Iran is most commonly nonalcoholic steatohepatitis 
(NASH). In our study we tried to demonstrate that the 
epidemiology of the HH and HFE gene mutation in Iran 
is completely different from that found in the West, and 
also to emphasize the infrequency of the C282Y mutation 
in Iran (2). In recent publications from countries such as 
India, similar results were found and all the data were in 
favor of a minor contributory role of HH in the develop-
ment of cirrhosis in these countries which is different 
from in the West (3). Finally I want to emphasize the ef-
fect that the presence of the HFE gene mutation has on 
the fibrogenesis of other liver diseases such as alcoholic 
or viral hepatitis (4) and this should be investigated in 
future studies in Iran. 
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